相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。From bench to bed and back again: phage therapy of childhood Escherichia coli diarrhea
Shafiqul A. Sarker et al.
NUTRITION AND THE MICROBIOME (2016)
Escherichia coli Harboring mcr-1 and blaCTX-M on a Novel IncF Plasmid: First Report of mcr-1 in the United States
Patrick McGann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Silk route to the acceptance and re-implementation of bacteriophage therapy
Wilbert Sybesma et al.
BIOTECHNOLOGY JOURNAL (2016)
Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition
Matthieu Galtier et al.
ENVIRONMENTAL MICROBIOLOGY (2016)
Targeting the gut to protect the bladder: Oral Phage therapy approaches against urinary Escherichia coli infections?
Harald Brussow
ENVIRONMENTAL MICROBIOLOGY (2016)
Alternatives to antibiotics-a pipeline portfolio review
Lloyd Czaplewski et al.
LANCET INFECTIOUS DISEASES (2016)
Pf4 bacteriophage produced by Pseudomonas aeruginosa inhibits Aspergillus fumigatus metabolism via iron sequestration
Jack C. Penner et al.
MICROBIOLOGY-SGM (2016)
When patients reach out, scientists should reach back carefully
Paul S. Knoepfler
NATURE MEDICINE (2016)
The Formulation of Bacteriophage in a Semi Solid Preparation for Control of Propionibacterium acnes Growth
Teagan L. Brown et al.
PLOS ONE (2016)
DRUG DEVELOPMENT Beleaguered phage therapy trial presses on
Kelly Servick
SCIENCE (2016)
Evolutionary Rationale for Phases as Complements of Antibiotics
Clara Torres-Barcelo et al.
TRENDS IN MICROBIOLOGY (2016)
Silk route to the acceptance and re-implementation of bacteriophage therapy
Wilbert Sybesma et al.
BIOTECHNOLOGY JOURNAL (2016)
Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences
Nina Chanishvili
CURRENT DRUG DELIVERY (2016)
T4 Phage Tail Adhesin Gp12 Counteracts LPS-Induced Inflammation In Vivo
Paulina Miernikiewicz et al.
FRONTIERS IN MICROBIOLOGY (2016)
Access to bacteriophage therapy: discouraging experiences from the human cell and tissue legal framework
G. Verbeken et al.
FEMS MICROBIOLOGY LETTERS (2016)
Phages targeting infected tissues: novel approach to phage therapy
Andrzej Gorski et al.
FUTURE MICROBIOLOGY (2015)
T4 bacteriophage-mediated inhibition of adsorption and replication of human adenovirus in vitro
Maciej Przybylski et al.
FUTURE MICROBIOLOGY (2015)
Re-establishing a place for phage therapy in western medicine
Elizabeth Martin Kutter et al.
FUTURE MICROBIOLOGY (2015)
Quality and Safety Requirements for Sustainable Phage Therapy Products
Jean-Paul Pirnay et al.
PHARMACEUTICAL RESEARCH (2015)
Phage therapy redux - What is to be done?
Ry Young et al.
SCIENCE (2015)
FDA as a catalyst for translation
Robert M. Calif et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Oral Application of T4 Phage Induces Weak Antibody Production in the Gut and in the Blood
Joanna Majewska et al.
VIRUSES-BASEL (2015)
Mammalian Host-Versus-Phage immune response determines phage fate in vivo
Katarzyna Hodyra-Stefaniak et al.
SCIENTIFIC REPORTS (2015)
The Effect of Bacteriophage Preparations on Intracellular Killing of Bacteria by Phagocytes
Ewa Jonczyk-Matysiak et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Bacteriophage Therapy: Advances in Formulation Strategies and Human Clinical Trials
Dieter Vandenheuvel et al.
ANNUAL REVIEW OF VIROLOGY, VOL 2 (2015)
Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection
Nathan B. Pincus et al.
PLOS ONE (2015)
Ethical Justifications for Access to Unapproved Medical Interventions: An Argument for (Limited) Patient Obligations
Mary Jean Walker et al.
AMERICAN JOURNAL OF BIOETHICS (2014)
Call for a Dedicated European Legal Framework for Bacteriophage Therapy
Gilbert Verbeken et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2014)
The microbiome revolution
Martin J. Blaser
JOURNAL OF CLINICAL INVESTIGATION (2014)
Immunogenicity Studies of Proteins Forming the T4 Phage Head Surface
Krystyna Dabrowska et al.
JOURNAL OF VIROLOGY (2014)
Phage Neutralization by Sera of Patients Receiving Phage Therapy
Marzanna Lusiak-Szelachowska et al.
VIRAL IMMUNOLOGY (2014)
The factors affecting effectiveness of treatment in phages therapy
Mai Huong Ly-Chatain
FRONTIERS IN MICROBIOLOGY (2014)
Phage cocktails and the future of phage therapy
Benjamin K. Chan et al.
FUTURE MICROBIOLOGY (2013)
T4 Phage and Its Head Surface Proteins Do Not Stimulate Inflammatory Mediator Production
Paulina Miernikiewicz et al.
PLOS ONE (2013)
Human nutrition, the gut microbiome and the immune system
Andrew L. Kau et al.
NATURE (2011)
Prophylactic effect of bacteriophages on mice subjected to chemotherapy-induced immunosuppression and bone marrow transplant upon infection with Staphylococcus aureus
Michai Zimecki et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2010)
Bacteriophage-Resistant Staphylococcus aureus Mutant Confers Broad Immunity against Staphylococcal Infection in Mice
Rosanna Capparelli et al.
PLOS ONE (2010)
Bacteriophages as potential new therapeutics to replace or supplement antibiotics
Mzia Kutateladze et al.
TRENDS IN BIOTECHNOLOGY (2010)
The Effects of T4 and A3/R Phage Preparations on Whole-Blood Monocyte and Neutrophil Respiratory Burst
Jan Borysowski et al.
VIRAL IMMUNOLOGY (2010)
A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses
Ryszard Miedzybrodzki et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2009)
Is phage therapy acceptable in the immunocompromised host?
Jan Borysowski et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes
Ryszard Miedzybrodzki et al.
VIRUS RESEARCH (2008)
Multicomponent anthrax toxin display and delivery using bacteriophage T4
Sathish B. Shivachandra et al.
VACCINE (2007)
Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines
Taheri Sathaliyawala et al.
JOURNAL OF VIROLOGY (2006)
Bacteriophage translocation
A Górski et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: A strategy for efficient display of large full-length proteins
SB Shivachandra et al.
VIROLOGY (2006)
Bacteriophages and transplantation tolerance
A Gorski et al.
TRANSPLANTATION PROCEEDINGS (2006)
Successful eradication of methicillin-resistant staphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker - Case report
P. Leszczynski et al.
FOLIA MICROBIOLOGICA (2006)
Human volunteers receiving Escherichia coli phage T4 orally:: a safety test of phage therapy
A Bruttin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
The potential role of endogenous bacteriophages in controlling invading pathogens
A Górski et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man
B Weber-Dabrowska et al.
TRANSPLANTATION PROCEEDINGS (2003)
Bacteriophage therapy
A Sulakvelidze et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
A comparison of observational studies and randomized, controlled trials.
K Benson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Randomized, controlled trials, observational studies, and the hierarchy of research designs.
J Concato et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
